| Financial Year |
March 31 2023 |
| Monetary Funds |
522,393,363.43 |
| Held-for-trading Financial Assets |
190.39 |
| Notes Receivable |
14,587,111.25 |
| Accounts Receivable |
205,737,316.04 |
| Advances to Suppliers |
18,718,468.34 |
| Other Receivables |
8,889,613.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
257,323.62 |
| Dividend Receivable |
-- |
| Inventories |
286,353,697.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
530,973.46 |
| Other Current Assets |
5,225,909.72 |
| Total Current Assets |
1,062,436,643.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,970,884.50 |
| Long-term Equity Investment |
134,615,175.94 |
| Investment Properties |
-- |
| Fixed Assetes |
230,756,421.95 |
| Under-construction Projects |
47,432,380.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,492,374.54 |
| R&D expenses |
-- |
| Goodwill |
175,091,816.61 |
| Long-Term Deferred and Prepaid Expenses |
7,111,940.70 |
| Deferred Income Tax Assets |
14,366,116.83 |
| Other Non-Current Assets |
17,628,811.65 |
| Sub-Total of Non-Current Assets |
1,295,635,377.84 |
| Total Assets |
2,358,072,021.45 |
| Short-Term Loans |
550,564,503.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,616,034.22 |
| Accounts Payable |
118,816,082.68 |
| Accounts Received In Advance |
650,430.00 |
| Employee Compensation Payable |
30,846,161.02 |
| Taxes Payable |
22,910,330.32 |
| Interest Payable |
79,108.38 |
| Dividend Payable |
162,637.00 |
| Other payables |
66,781,490.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,675,558.80 |
| Other Current Liabilities |
6,982,150.11 |
| Sub-Total of Current Liabilities |
933,181,345.32 |
| Long-term Loans |
2,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
134,612,020.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,464,049.00 |
| Deferred Income Tax Liabilities |
57,918,396.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
290,647,067.59 |
| Total Liabilities |
1,223,828,412.91 |
| Paid-In Capital(Or Share Stock) |
577,171,949.00 |
| Capital Surplus |
75,513,424.28 |
| Surplus Reserve |
109,056,112.79 |
| LESS:Treasury Stock |
85,287,946.18 |
| Undistributed Profits |
420,825,628.49 |
| Minority Stockholder's Interest |
28,036,831.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,106,206,777.37 |
| Owner's Equity（Stockholder's Equity） |
1,134,243,608.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,358,072,021.45 |
